Fecal Transplant for Pediatric Patients Who Have Recurrent C-diff Infection (FMT)
Fecal Microbiota Transplantation (FMT) for Recurrent or Refractory C. Difficile Infection (CDI) in Pediatric and Young Adult Patients
Sponsor: Jonathan Gisser
This PHASE1 trial investigates Clostridium Difficile and is currently ongoing. Jonathan Gisser leads this study, which shows 13 recorded versions since 2013 — indicating substantial longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
13 versions recorded-
Nov 2025 — Present [monthly]
Unknown PHASE1
Status: Recruiting → Unknown
-
Sep 2024 — Nov 2025 [monthly]
Recruiting PHASE1
-
Jul 2024 — Sep 2024 [monthly]
Recruiting PHASE1
-
Oct 2023 — Jul 2024 [monthly]
Recruiting PHASE1
-
Apr 2022 — Oct 2023 [monthly]
Recruiting PHASE1
▶ Show 8 earlier versions
-
Jan 2021 — Apr 2022 [monthly]
Recruiting PHASE1
-
Aug 2020 — Jan 2021 [monthly]
Recruiting PHASE1
-
Dec 2019 — Aug 2020 [monthly]
Recruiting PHASE1
-
Sep 2018 — Dec 2019 [monthly]
Recruiting PHASE1
-
Jun 2018 — Sep 2018 [monthly]
Recruiting PHASE1
-
Apr 2017 — Jun 2018 [monthly]
Recruiting PHASE1
Status: Unknown Status → Recruiting
-
Feb 2017 — Apr 2017 [monthly]
Unknown Status PHASE1
-
Jan 2017 — Feb 2017 [monthly]
Unknown Status PHASE1
First recorded
Dec 2013
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Jonathan Gisser
For direct contact, visit the study record on ClinicalTrials.gov .